SiPore engineered-silica non-drug technology for prediabetes and weight control
| Date | Round | Amount |
|---|---|---|
| Oct 2023 | Funding round Stockholm-based Sigrid Therapeutics raised an oversubscribed 4M USD round to commercialize its SiPore silica technology for obesity and diabetes. | $4M |
| Jan 2023 | Funding round Stockholm health-tech Sigrid Therapeutics raised SEK10.6M (~EUR536K) in an oversubscribed rights issue. | $536.3K |